30 Day Trial

Alphatec Reports Preliminary 3Q17 Revenue

Share:

Alphatec Spine reported preliminary, unaudited 3Q17 revenue in a range of US $22.8MM to $23.1MM.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.